IGF::OT::IGF Aerosolized Delivery of Anti-Tubercular Drugs
$210,507N43FY2013AINIH
Pai Life Sciences, Inc., Seattle WA
Investigators
Abstract
Develop an inexpensive, easy to use, aerosolized delivery system of a combination of anti-tubercular drugs that could be used for the treatment of multi-drug resistant tuberculosis (MDR TB ).
View original record on NIH RePORTER →